BrainCool Inc. is a subsidiary of BrainCool AB (publ) an innovative medical device company committed to advancing temperature management solutions. We are focused on making advanced temperature management therapy more accessible, more efficient, and more cost effective. The BrainCool Inc. portfolio includes the IQool™ System and the Cooral® System. The IQool™ System allows clinicians to begin advanced temperature management therapy in minutes and provides important data points throughout the therapy. The Cooral® System has recently been approved though a De Novo clearance by the U.S. Food and Drug Administration (FDA) and offers clear benefits for patients undergoing chemotherapy.

BrainCool’s core values are Innovation, Simplicity and Responsiveness. We understand the professionals we serve are making a positive difference and are honored to play a part in advancing patient care. Contact us at info@braincoolinc.com for additional information.

Our Leadership Team

Martin Waleij Chief Executive Officer
Troy Van Der Veur Executive Vice President, BrainCool Inc.
Christian Strand Executive Vice President, Oncology
Lindsey VerweyNational Clinical Manager
Tara JaafLead Biomedical Engineer